Dendritic cells (DCs) play a key role in the generation of CD4 T cell responses to pathogens.
INTRODUCTION
Critical to the success of Mycobacterium tuberculosis (Mtb) as a pathogen is its ability to evade host innate and adaptive immunity. Mtb dampens macrophage functions and impairs the ability of dendritic cells (DCs) to induce optimal antigen-specific CD4 T cell responses. As the major APC in the immune system, DCs are central to the generation of CD4 T cell responses after infection and vaccination. However, immunomodulatory factors expressed by Mtb promote sub-optimal DC maturation, cytokine production, and antigen presentation to CD4
We have previously demonstrated that an Mtb cell wall-associated serine protease, Hip1 (Hydrolase important for pathogenesis 1, Rv2224c), is involved in impairing DC functions. 6 Because Hip1 from BCG and Mtb are 100% identical, we hypothesized that BCG Hip1 may contribute to sub-optimal DC and CD4 T cell responses and that deletion of hip1 from BCG would augment innate and adaptive immune responses. In this study, we generated a BCG (Danish) strain lacking hip1 (BCGΔhip1) to investigate whether deletion of hip1 in BCG enhances DC functions and improves CD4 T cell responses in vitro and in vivo. We show that DCs infected with BCGΔhip1 produce significantly enhanced levels of pro-inflammatory cytokines and express higher levels of MHC class II and costimulatory molecules compared with the DCs infected with the parent BCG strain. Additionally, dele- 
MATERIALS AND METHODS

Bacterial strains and culture conditions
BCG (Danish), BCGΔhip1, and BCGΔhip1 complemented with hip1 (BCGΔhip1 comp) were grown at 37 • C in Middlebrook 7H9 broth supplemented with 10% oleic acid-albumin-dextrose-catalase (OADC), 0.2% glycerol, and 0.05% Tween 80 or on Middlebrook 7H10 agar supplemented with 10% OADC, 0.5% glycerol, and 0.2% Tween 80. Media for complemented BCGΔhip1 was supplemented with 20 g/mL of streptomycin (Sigma-Aldrich, St. Louis, MO). For growth curves, bacterial strains were inoculated into supplemented 7H9 medium at OD 600 0.05, and the OD 600 measurements were taken daily.
Construction of BCG hip1 and complemented strains
BCG was transformed via electroporation with 3 g of pEBOP-2 (pYUB657 suicide vector containing a Δhip1 allele, a selectable hygromycin resistance marker, and a counter selectable sacB marker).
Resulting transformants that were resistant to hygromycin were then patched onto 7H10 plates containing 2% sucrose and 50 g/mL of hygromycin (Roche Diagnostics, Indianapolis, IN). Colonies that displayed hygromycin resistance and sucrose sensitivity were considered to have undergone a single crossover event resulting in incorporation of pEBOP-2 into the BCG genome. These colonies were then grown to saturation for a week in 5 mL of 7H9 broth, and then serial dilutions were plated in duplicate onto 7H10 plates supplemented with 2% sucrose. Colonies arising on these plates were patched onto hygromycin-containing plates. Colonies that were both hygromycin sensitive and sucrose resistant were grown in 7H9 broth, and genomic DNA was extracted using the protocol adapted from Belisle and Sonnenberg. 7 Genomic DNA was then subjected to Southern blot analysis. DNA was digested with NcoI, and then probed with a DIG-labeled DNA amplicon corresponding to a 1 kb region present in both the genome and pEBOP-02. Deletion of hip1 was also confirmed via amplification of the deleted region using primers upstream (forward primer 5 ′ -CGGCCACCCGCTCACCGCCCTCG-3 ′ ) and downstream (reverse primer 5 ′ -GCACGGCGAATGTCAGATAGGG-3 ′ ) of the 1 kb regions of homologous recombination, resulting in a 4.5 kb amplicon from the BCGΔhip1 genome, and a 6 kb amplicon from the wildtype BCG genome (Supplemental Fig. 1C) . These amplicons were then sequenced for further confirmation of gene deletion. BCGΔhip1 was complemented with hip1 expressed from its natural promoter on an integrated plasmid.
Mice
All mice were housed under specific pathogen-free conditions in filtertop cages within the vivarium at the Yerkes National Primate Center, Emory University, and provided with sterile water and food ad libitum.
C57BL/6J mice were purchased from The Jackson Laboratory (Bar Harbor, ME). OT-II TCR transgenic mice specific for OVA 323-339 peptide were obtained from Dr. Bali Pulendran (originally generated in the laboratory of Dr. F. Carbone, University of Melbourne), and bred at the Yerkes animal facility.
BMDM and BMDC generation and infection
Bone marrow-derived macrophages (BMDMs) were generated as previously described. 8 Bone marrow cells were isolated from C57BL/6J mice and differentiated for 7 days at 37 • C with 5% CO 2 in DMEM/F-12 medium (Lonza, Walkersville, MD) containing 10% FBS (HyClone, Logan, UT), 2 mM L-glutamine, and 10% L-cell conditioned medium (LCM). Adherent cells were collected, and macrophages were plated onto 24-well plates at 3 × 10 5 per well and rested overnight. For heatkilled BCG infections, bacteria suspended in DMEM/F-12 medium containing 10% FBS, 2 mM L-glutamine, and 5% LCM were added to differentiated BMDMs in 24 well plates at indicated MOIs. Murine bone marrow-derived dendritic cells (BMDCs) were generated as previously described. 9 Bone marrow cells isolated from C57BL/6J mice were grown and differentiated for 8 days in RPMI medium (Lonza) 
BMDC-T cell cocultures
BMDCs were cocultured with CD4 T cells 24 hours after infection with BCG strains. Briefly, CD4 T cells were isolated from splenocytes collected from OT-II TCR transgenic mice and purified using CD4 magnetic microbeads (Miltenyi). Purified CD4 T cells were suspended at 1 × 10 6 /mL in supplemented RPMI and cocultured with BMDCs to achieve a 1:4 DC:T cell ratio. Supernatants from cocultures were collected after 72 hours, spun down to remove cells, and frozen. Cytokine levels were analyzed via ELISA according to manufacturers' instrucutions: IFN-(Mabtech, Cincinnati, OH), IL-2 (BD Biosciences), and IL-17 (eBioscience, San Diego, CA).
Intratracheal instillation of BMDCs
BMDCs were generated as described, purified using CD11c microbeads (Miltenyi), and stimulated with either BCG or BCGΔhip1 at an MOI of 30 or left unstimulated in media for 24 hours. BMDCs were then washed, resuspended in PBS, and intratracheally instilled (1 × 10 6 per mouse in 50 L PBS) into isoflurane-anesthetized C57BL/6J hosts.
Assessment of antigen-specific responses
Six days after intratracheal BMDC transfer, lungs were harvested and processed for further analysis. Briefly, organs were minced and placed in harvest medium consisting of HBSS containing 10 mM HEPES, 2% FBS, 0.1% collagenase type IV (Worthington, Lakewood, NJ), and 0.01% DNase I (Worthington) for 30 min at 37 • C. Following incubation, organs were processed into single cell suspension utilizing the gentleMACs tissue dissociator (Miltenyi). Cells were thoroughly washed, counted, and 1 × 10 6 cells were plated for phenotypic analysis or antigen restimulation. Cells were exposed to media (unstimulated), PMA/ionomycin (80 and 500 ng/mL, respectively), or 10 g/mL whole cell lysate (WCL). Cells were then incubated at 37 • C for 1.5 hours before addition of BFA (5 g/mL) and monensin 
Mtb aerosol challenge and enumeration of bacteria
Groups of five mice were intratracheally instilled with 1 × 10 6 BMDCs, rested for 14 days, and then challenged with a low dose (∼100 CFU)
of Mtb H37Rv using an Intox aerosol apparatus. Lungs from infected mice were harvested 28 days post-challenge, homogenized, plated on 7H10 agar plates, and incubated for 21 days in 37 • C prior to CFU enumeration.
RESULTS
Construction of a BCG hip1 strain
To determine the role of hip1 in BCG-induced DC responses, we generated an in-frame, unmarked deletion of hip1 in the BCG Danish strain. We utilized the suicide vector, pYUB657, which expresses a hygromycin resistance cassette and a counter-selectable marker, to introduce an allelic exchange-based deletion of hip1 (Supplemental Fig. 1A ). The resulting BCGΔhip1 strain harbored a complete deletion of hip1 from its genome, which we verified via PCR amplification of the genomic region as well as through Southern blot analysis (Supplemental Figs. 1B and C). Next, we sought to determine the effect of deleting hip1 on BCG growth kinetics. We observed no significant differences between BCG, BCGΔhip1, or a BCGΔhip1 strain complemented with hip1 (BCGΔhip1 comp) on growth in 7H9 broth (Fig. 1A) .
Additionally, these strains grew comparably in BMDCs over 5 days of culture (Fig. 1B) .
BCG hip1 elicits robust DC cytokine responses compared with BCG
DC cytokine production is a canonical signal driving differentiation of naïve CD4 T cells to specific CD4 T-helper (Th) subsets. We therefore sought to compare cytokine responses from DCs infected with BCG or BCGΔhip1. We infected BMDCs from C57BL/6J mice with BCG, BCGΔhip1, or BCGΔhip1 comp and measured DC cytokine production by ELISA. DCs infected with BCGΔhip1 produced significantly higher levels of IL-6 and IL-12p40 than DCs infected with BCG. Importantly, cytokine levels induced by BCGΔhip1 were restored to BCG levels after infection with the complemented strain ( Fig. 2A) , indicating that BCG limits DC cytokine production through hip1. We next infected
DCs with BCG or BCGΔhip1 at multiplicities of infection (MOI) of 10 was not dependent on viability of the bacteria (Fig. 2C) . Further, we
found that BMDMs infected with BCGΔhip1 produced higher levels of IL-6 and IL-1 compared with BCG-infected BMDMs at all MOIs tested (Fig. 2D ). These data demonstrate that deletion of hip1 in BCG results in significantly augmented pro-inflammatory cytokine production from both infected DCs and macrophages. (Fig. 3) . These data suggest that deletion of hip1 in BCG enhances DC maturation and expression of costimulatory molecules.
BCG hip1 enhances expression of costimulatory molecules on infected DCs
Enhanced polarization of IFN-and IL-17-producing antigen-specific CD4 T cells by DCs infected with BCG hip1
IL-12 is known to drive the polarization of IFN--producing Th 1 subsets, whereas IL-6, IL-1 , TGF-, and IL-23 drive the polarization and expansion of IL-17-producing Th 17 subsets. 10 Since DCs infected with BCGΔhip1 induced higher levels of pro-inflammatory cytokines (Fig. 2) and displayed an enhanced maturation profile (Fig. 3) 
Intratracheal instillation of DCs infected with BCG hip1 enhances lung CD4 T cell responses in vivo and improves control of Mtb burden following aerosol challenge
Mucosal administration of DCs has been utilized to assess early antigen-specific T cell responses to mycobacteria in the lungs of mice, 12 Values are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001; ns, no significance; ui, uninfected F I G U R E 3 BCG∆hip1 enhances expression of costimulatory molecules on infected DCs. BMDCs from C57BL/6J mice were either uninfected, infected with BCG or BCG∆hip1 (MOI 10), or stimulated with LPS (1 g/mL) for 24 hours. BMDCs were then stained for maturation markers CD86 (top), CD40 (middle), and MHC class II (bottom). Representative histograms (left) and summary graphs (right) of median fluorescence intensities of each marker is shown. Cells were pre-gated on live, CD11c + CD11b + singlets. Results are representative of 3 independent experiments. Statistical significance was determined by unpaired two-tailed Student's t-test. Values are presented as mean ± SD. * P < 0.05, ** P < 0.01, **** P < 0.0001; ns, no significance following restimulation with WCL. We found higher numbers of antigen-specific CD4 T cells producing IL-2, IFN-, TNF-, and IL-17 in the lungs of mice that received BCGΔhip1 DCs compared with BCG DCs (Fig. 5C ). Triple cytokine-producing CD4 T cells, conventionally termed polyfunctional CD4 T cells, are thought to be indicative of a more protective adaptive immune response. 16 Interestingly, we observed higher frequencies of CD4 T cells producing IFN-, IL-2, and TNF-in animals that received BCGΔhip1 DCs compared with BCG DCs (Fig. 5D ). To investigate whether mucosal administration of DCs exposed to BCGΔhip1 would provide enhanced bacterial control compared with BCG after low dose aerosol Mtb challenge, we intratracheally instilled BCG DCs or BCGΔhip1 DCs, rested mice for 2 weeks prior to aerogenic challenge with low-dose Mtb H37Rv, and determined lung Mtb bacterial burden 4 weeks post-challenge. As shown in Fig. 5E , mice that received BCGΔhip1-infected DCs harbored significantly less Mtb CFU post-challenge compared with mice that received BCG-infected DCs (Fig. 5E ). These results demonstrate that mucosal-targeted approaches using BCGΔhip1 can augment antigen-specific CD4 T cell responses compared with BCG and lead to enhanced control of Mtb burden.
DISCUSSION
The interplay between mycobacteria and DCs is a critical consideration for rational development of efficacious vaccines for TB. In this study, we demonstrate that deletion of the BCG serine protease, Hip1, promotes robust DC activation and enhances antigen-specific lung CD4 T cell responses. We have shown that BCGΔhip1-infected DCs produce higher levels of cytokines, express elevated levels of costimulatory molecules, and enhance CD4 T cell responses both in vitro and in vivo compared with DCs infected with BCG. These data provide insight into the sub-optimal immunogenicity of BCG and demonstrate that deletion of the immune evasion gene, hip1, in BCG proteins from Mtb, [20] [21] [22] [23] and expression of host proteins. [24] [25] [26] [27] [28] [29] [30] The majority of studies utilizing recombinant or mutant strains of BCG are primarily focused on enhancing macrophage driven responses and functions, such as phagasomal maturation, apoptosis of infected macrophages, and bacterial escape from phagasomal compartments. [31] [32] [33] [34] [35] [36] For instance, a recombinant strain of BCG lacking urease production and expressing listeriolysin from Listeria monocytogenes (BCGΔureC::hly) was shown to enhance apoptosis of infected macrophages, 33 leading to increased central memory T cell responses, 37 enhanced Th 1 and Th 17 immunity, 38 and cross-presentation to CD8 T cells. 34 Interestingly, deletion of antiapoptotic gene nuoG in BCGΔureC::hly showed enhanced efficacy over BCGΔureC::hly. 39 Notably, we show evidence that BCGΔhip1-infected macrophages display enhanced cytokine production relative to BCG-infected macrophages (Fig. 2) . As we utilized a mucosal transfer approach that exclusively utilized DCs, it will be important to address the role that macrophages may play at priming antigen-specific CD4
and CD8 T cell responses after vaccination with BCGΔhip1.
Relatively few studies have elaborated on BCG factors that can be targeted to improve DC responses. However, targeting DCs has proven to be a viable approach to improve Mtb-specific CD4 T cell responses after vaccination. H56, a subunit vaccine incorporating Ag85B, ESAT-6, and Rv2660, was shown to provide enhanced protection relative to BCG, 40 and utilizes a liposome-based adjuvant (CAF01) Values are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001; ns, no significance that targets DCs. 41 Furthermore, improving DC antigen-presentation by induction of autophagy has been shown to improve BCG immunogenicity and improve control of Mtb burden after challenge. 42 Our data show that transfer of BCGΔhip1-DCs leads to enhanced lung CD4
T cell responses compared with the transfer of BCG-DCs, including higher frequencies of antigen-specific, polyfunctional CD4 T cells contributing to better control of Mtb burden after challenge (Fig. 5) .
Thus, our studies suggest that deleting BCG hip1 alone, or in concert with deleting additional immune evasion genes, is a feasible approach to enhance DC functions for the rational improvement of BCG as a vaccine. A growing number of studies indicate that vaccination through the mucosal route induces robust antigen-specific responses that confer better protection at mucosal surfaces, such as the lung, relative to parenteral routes. 9, 13, 14, [43] [44] [45] [46] [47] [48] Using an intratracheal DC installation wrote the manuscript. J.R., E.B., J.K.S., and A.E. reviewed and edited the manuscript.
